DLH Wins Renewal of National Institute of Health Contract for Epidemiologic and Public Health Support
April 21 2022 - 09:22AM
DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a
leading health and human services provider to the federal
government, today announced it has been awarded a contract to
continue providing epidemiologic and public health support to the
National Institute of Diabetes and Digestive and Kidney Diseases
(“NIDDK”). NIDDK is an institute of the National Institutes of
Health (“NIH”). DLH has held this work since this contract was
first awarded in 1987.
The contract includes a base period of one year
with four one-year options, for a total value of approximately $14
million. Under this award, DLH will support NIDDK led research into
diabetes, digestive, kidney, and other chronic diseases through
epidemiological research and biostatistical consultation, data
management, statistical programming, data analysis, cloud
computing, machine learning, and natural language processing. DLH
will also collaborate and coordinate with the National Center for
Health Statistics (“NCHS”) in planning, developing, and
implementing surveys.
“DLH is honored to continue our long-standing
partnership with NIDDK, supporting the research they lead to create
knowledge about and treatments for some of the most consequential
and burdensome public health concerns today,” said Jeanine
Christian, President of DLH’s Public Health & Scientific
Research operating unit. “Chronic diseases are a major cause of
premature death around the world and a leading cause of death and
disability in the United States – and we are proud to support NIDDK
and their research as the institute works towards preventing
disease, prolonging life, and promoting public health.”
“DLH’s world-class researchers, analysts, and
programmers work each day alongside our partners at NIDDK to
improve the health and quality of life of those suffering from
diabetes and other chronic diseases,” said Zach Parker, DLH
President and CEO. “DLH is proud of its long-standing customer
relationship with NIDDK and is excited for the opportunity to
continue leveraging Infinibyte® Cloud, our secure data analytics
solution, and our experience in epidemiology and data analytics, in
support of such a vital health mission.”
About DLHDLH (NASDAQ:DLHC)
delivers improved health and readiness solutions for federal
programs through research, development, and innovative care
processes. The Company’s experts in public health, performance
evaluation, and health operations solve the complex problems faced
by civilian and military customers alike, leveraging digital
transformation, artificial intelligence, advanced analytics,
cloud-based applications, telehealth systems, and more. With over
2,300 employees dedicated to the idea that “Your Mission is Our
Passion,” DLH brings a unique combination of government sector
experience, proven methodology, and unwavering commitment to public
health to improve the lives of millions. For more information,
visit http://www.DLHcorp.com.
INVESTOR RELATIONSContact:
Chris WittyPhone: 646-438-9385Email: cwitty@darrowir.com
DLH (NASDAQ:DLHC)
Historical Stock Chart
From Feb 2024 to Mar 2024
DLH (NASDAQ:DLHC)
Historical Stock Chart
From Mar 2023 to Mar 2024